catalyst pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, including lambert-eaton myasthenic syndrome (lems), congenital myasthenic syndromes (cms), in

Catalyst Pharmaceutical  Inc.

Bought 100% more CPRX

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Lucas K

Sold all CPRX

Nopatel

New position in CPRX

Britt

Dabin Choi

Bought 48% more CPRX

Sold 58% of CPRX

Sold 45% of CPRX

Mike Pelech

Bought 83% more CPRX